Skip to main content

β-Adrenoceptor Blocking Drugs and the Renin-Angiotensin System

  • Chapter
Clinical Pharmacology & Therapeutics

Abstract

Biological tests of the hypertension work-up are used for two different purposes: to determine diagnosis and treatment and to detect rare diseases. For all patients, it is useful to conduct initial tests of plasma creatinine and potassium, and, very often, of plasma glucose, cholesterol and uric acid. A second group of tests is useful in a few patients for detection of surgically curable causes of hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alhenc-Gelas, F., Plouin, P. F., Ducrocq, M. B., Corvol, P. & Menard, J. (1978). Comparison of the antihypertensive and hormonal effects of a cardio-selective beta-blocker, acebutolol, and diuretics in essential hypertension. Am. J. Med., 64, 1005–1012.

    Article  CAS  PubMed  Google Scholar 

  • Birkenhäger, W. H., de Leeuw, P. W., Wester, A., Kho, T. L., Vandongen, R. & Falke, H. E. (1977). Therapeutic effects of beta-adrenoceptor blocking agents in hypertension. In Advances in Internal Medicine and Pediatrics, ed. von Herausgegeben, P., Frick, G. A., von Harnack, G. A., Martini, A., Prader, R., Shoen, R. & Wolff, H. P. pp. 117–134. Springer-Verlag: Berlin, Heidelberg.

    Google Scholar 

  • Bravo, E. L., Tarazi, R. C., & Dustan, H. P. (1975). Beta-adrenergic blockade in diuretic-treated patients with essential hypertension. New Eng. J. Med., 292, 66–70.

    Article  CAS  PubMed  Google Scholar 

  • Bühler, F. R., Burkart, F., Lutold, B. E., Kung, M., Marbet, G. & Pfisterer, M. (1975). Antihypertensive beta-blocking action as related to renin and age. A pharmacological tool to identify pathogenetic mechanism in essential hypertension. Am. J. Cardiol., 36, 653–669.

    Article  PubMed  Google Scholar 

  • Bühler, F. R., Laragh, J. H., Baer, L., Vaughan, E. D., Jr. & Brunner, H. R. (1972). Propranolol inhibition of renin secretion: a specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. New Eng. J. Med., 287, 1209–1214.

    Article  PubMed  Google Scholar 

  • Collste, P. & Haglund, K. (1979). Time-course of blood pressure decrease during initiation of antihypertensive treatment with metoprolol. In 6th Scientific Meeting of the ISH, p. 126 Goteborg, June 11–13.

    Google Scholar 

  • Distler, A., Keim, H. J., Cordes, U., Philipp, T. & Wolff, H. P. (1978). Sympathetic responsiveness and antihypertensive effect of beta-receptor blockade in essential hypertension. Am. J. Med., 64, 446–541.

    Article  CAS  PubMed  Google Scholar 

  • Ducrocq, M. B., Degoulet, P., Charpentier, A., Corvol, P. & Menard, J. (1975). Le test à l’acébutolol dans l’hypertension artérielle modérée. Action sur les intervalles de temps systoliques. Nouv. Presse méd., 4, 3268–3272.

    CAS  PubMed  Google Scholar 

  • Hansson, L. (1973). Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity. Acta med. Scand., 550, 1–40.

    CAS  Google Scholar 

  • Kreft, C., Menard, J. & Corvol, P. (1979). Value of renin measurement, saralasin test and acebutolol treatment in hypertension. Kidney Int., 15, 176–183.

    Article  CAS  PubMed  Google Scholar 

  • Laragh, J. H. (1976). Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: a primary role for beta-blocking drugs such as propranolol. Am. J. Med., 61, 797–810.

    Article  CAS  PubMed  Google Scholar 

  • Lehtonen, A. (1976). Atenolol in hypertension. Acta Ther., 2, 125–131.

    Google Scholar 

  • Meekers, J., Missotten, A., Fagard, R., Demuynck, D., Harvengt, C., Pas, P., Billiet, L. & Amery, A. (1975). Predictive value of various parameters for the antihypertensive effect of the beta-blocker ICI 66, 082. Arch. int. Pharmacodvn. Ther., 213, 294–307.

    CAS  Google Scholar 

  • Menard, J., Bertagna, X., N’Guyene, P. T., Degoulet, P. & Corvol, P. (1976). Rapid identification of patients with essential hypertension sensitive to acebutolol. Am. J. Med., 60, 886–890.

    Article  CAS  PubMed  Google Scholar 

  • Menard, J. & Corvol, P. (1980): L’inhibition du système rénine-angiotensine: un progrès majeur dans le traitement de l’Hypertension Artérielle? Nouv. Presse méd., 9, 579–583.

    CAS  PubMed  Google Scholar 

  • Plouin, P. F., Alhenc-Gelas, F., Degoulet, P., Corvol, P. & Menard, J. (1980). Importance and limitation of PRA measurement for the choice of initial medication in ‘stepped-care’ treatment of hypertension. Cardiovasc. Rev. Rep., 1, 31–37.

    Google Scholar 

  • Plouin, P. F., Comoy, E., Bohuon, C., Corvol, P. & Menard, J. (1979). Activité rénine et noradrénaline plasmatiques au cours du traitement antihypertenseur par l’acebutolol. Nouv. Presse méd., 8, 1905–1909.

    CAS  PubMed  Google Scholar 

  • Plouin, P. F., Menard, J., Corvol, P. & Milliez, P. (1978). Incidence des bêta-bloquants sur l’activité reénine plasmatique. Point Actuel. Nouv. Presse méd., 7, 2769–2774.

    CAS  PubMed  Google Scholar 

  • Stokes, G. S., Weber, M. A., Smith, J. V. & Gain, J. M. (1976). Double-blind cross-over study of propranolol and spironolactone in hypertension and plasma renin measurements in relation to therapeutic effects. In Systemic effects of antihypertensive agents, ed. Sambhi, M. P., pp. 265–284. New York: Stratton Intercontinental Medical Book Corporation.

    Google Scholar 

  • Thibonnier, M., Lardoux, M. D. & Corvol, P. (1980). Comparative trial of labetalol and acebutolol, alone or associated with dihydralazine, in treatment of essential hypertension. Brit. J. clin. Pharmac., 9, 561–567.

    Article  CAS  Google Scholar 

  • Vaughan, E. D., Jr., Laragh, J. H., Gavras, I., Bühler, F. R., Gavras, H., Brunner, H. R. & Baer, L. (1973). Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone. Am. J. Cardiol., 32, 523–532.

    Article  PubMed  Google Scholar 

  • Woods, J. W., Pittman, A. W. & Pulliam, C. C. (1976). Renin profiling in the treatment of hypertension. New Eng. J. Med., 294,1137–1143.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

P. Turner C. Padgham A. Hedges

Copyright information

© 1980 The contributors

About this chapter

Cite this chapter

Menard, J., Bautier, P., Plouin, P.F., Thibonnier, M., Corvol, P. (1980). β-Adrenoceptor Blocking Drugs and the Renin-Angiotensin System. In: Turner, P., Padgham, C., Hedges, A. (eds) Clinical Pharmacology & Therapeutics. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-05952-2_28

Download citation

Publish with us

Policies and ethics